Sona Nanotech Inc C.SONA

Alternate Symbol(s): SNANF

Healthcare Biotechnology

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.

CSE:SONA - Post by User

Sona Nanotech Inc

Bullboard Posts

Comment by bluebeard123on Aug 07, 2020 8:18pm

108 Views

Post# 31381633

RE:RE:RE:RE:False positives

I hope this is right that QDEL and BD have to go through independent validation. That would give good comparison against Sona. It will probably eork in favour of Sona. There needs to be a level playing field.

Pandora wrote:
This also on the Yahoo board:

"I think Quidel and BDX has to go through FDA new Antigen guidelines with 60 days. They have to provide independent validation with clinical trial same as Sona is going thru now. It will be survival of the fittest among 3 Antigen 5-15min test so far developed."

Bullboard Posts

Day trading vs. swing trading strategies for small-cap stocks